Related Experiment Video
Updated: May 28, 2025
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.0K
A Novel ACVR2A::RAF1 Fusion in Spindle Cell Sarcoma
Anfeng Jiang1, Huan Li2,3, Dongbing Li2,3
1Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Genes, Chromosomes & Cancer
|February 14, 2025
Summary
A novel ACVR2A::RAF1 fusion was identified in a recurrent cranial base sarcoma. Targeted therapy with Trametinib resulted in significant tumor shrinkage and pain relief, demonstrating the value of molecular diagnostics.
Area of Science:
- Oncology
- Genomics
- Molecular Pathology
Background:
- Kinase-rearranged spindle cell sarcomas possess distinct molecular characteristics.
- Next-generation sequencing (NGS) aids in identifying kinase fusions for precise tumor classification.
Purpose of the Study:
- To report a novel ACVR2A::RAF1 fusion in a patient with recurrent cranial base sarcoma.
- To evaluate the efficacy of targeted therapy based on molecular findings.
Main Methods:
- Histological and immunohistochemical analysis of tumor tissue.
- Next-generation sequencing (NGS) to identify genetic alterations.
- Treatment with a MEK1 inhibitor (Trametinib).
Main Results:
- Identification of a novel ACVR2A::RAF1 fusion.
- Patient treated with Trametinib showed significant tumor shrinkage and pain relief on MRI.
- The fusion protein likely activates RAF1 signaling.
Conclusions:
- The ACVR2A::RAF1 fusion is a novel genomic alteration in RAF1-rearranged spindle cell sarcoma.
- Targeted therapy based on molecular diagnostics can yield significant clinical benefits.
- This case underscores the importance of molecular profiling for guiding cancer treatment.
More Related Videos
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
928
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
9.5K
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
02:38The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
01:07MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K